Palmitoylethanolamide on the European supplement market
Most ingredient pages tell you what Palmitoylethanolamide is. This one shows how the European supplement market actually uses it — who sells it, who advertises it, and at what price.
RavenBI Market Intelligence · measured 25 Oct 2026 · observed, not estimated. Ad counts are active creatives in Meta's public Ad Library; product and price data come from public listings across the EU and US. Figures change weekly.
RavenBI tracks 179 Palmitoylethanolamide products from 104 brands across the EU and US. 29 brands advertise it on Meta right now, and new-ad activity cooled 55% in the last 30 days. Austria shows the heaviest advertising, while Germany has the largest shelf. The median EU shelf price sits around €30.
New Palmitoylethanolamide ads launched per month on Meta — last 6 months.
How brands use Palmitoylethanolamide, market by market
Products and brands that sell it, active ads and brands that advertise it, and the median shelf price — per market.
| Market | Products | Brands selling | Active ads | Brands advertising | Median price |
|---|---|---|---|---|---|
| Germany | 39 | 14 | 18 | 2 | €32.79 |
| United Kingdom | 39 | 19 | — | — | £36.45 |
| France | 20 | 14 | 17 | 3 | €25.00 |
| Italy | 17 | 14 | 31 | 5 | €25.95 |
| Spain | 26 | 18 | 59 | 14 | €35.47 |
| Romania | 17 | 8 | 6 | 3 | 125.00 RON |
| United States | 12 | 10 | — | — | $45.97 |
| Austria | 3 | 3 | 97 | 1 | — |
Who is on the shelf right now
Top brands by number of Palmitoylethanolamide products, and the forms they use.
Most-used forms
| Form | Products |
|---|---|
| Palmitoiletanolamidă | 84 |
| Palmitoylethanolamide (PEA) | 58 |
| Palmitoiletanolamidă (micronized) | 5 |
| Palmitoylethanolamide (90% with LipiSperse) | 5 |
| Palmitoiletanolamidă (OptiPEA®) | 4 |
| Palmitoiletanolamidă (ultra-micronized) | 4 |
Regulatory & positioning
| Botanical source | Palmitoylethanolamide |
|---|---|
| Novel food status | — |
| EFSA authorized health claims | None authorized |
| Marketed categories (observed) | joint health |
No EFSA-authorized health claim exists for Palmitoylethanolamide, yet brands market it for joint health — the gap between claim and positioning is itself a competitive signal.
Where Palmitoylethanolamide shows up
Across the ad channels and marketplaces RavenBI tracks.
See the ads, listings and shops behind these numbers →
What is Palmitoylethanolamide?
Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide belonging to the class of endogenous lipid mediators. It is commonly incorporated in dietary supplements, particularly those marketed for joint health and general wellness. PEA is often used in formulations targeting comfort and mobility, frequently combined with other ingredients such as vitamins, minerals, and botanical extracts. Its inclusion in supplement products reflects interest in its role as a signaling lipid involved in cellular processes. Formulators may consider PEA for its compatibility with various delivery formats including capsules, tablets, and powders.
This overview was generated with AI from public information and RavenBI's classification. Informational only, not medical advice.
30,000+ ingredients tracked across the EU + US · Live competitor ads, prices and product claims · Spot under-served demand in each market before rivals do.
Start free trial — full access